Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.
about
Glycemic control: a combination of lifestyle management and the use of drugsComparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.Initiating insulin in patients with type 2 diabetes.Enhanced acarbose production by Streptomyces M37 using a two-stage fermentation strategy.Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study.Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.Pharmacy research at URI: mining red maple (Acer rubrum) trees for novel therapeutics to manage diabetes.Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot studyEffects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial.Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.On the potential of acarbose to reduce cardiovascular disease.Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation.Pharmacologic treatment of type 2 diabetes: oral medications.Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Efficacy of fibre additions to flatbread flour mixes for reducing post-meal glucose and insulin responses in healthy Indian subjects.Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Effect of fibre additions to flatbread flour mixes on glucose kinetics: a randomised controlled trial.Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.Highly improved acarbose production of Actinomyces through the combination of ARTP and penicillin susceptible mutant screening.Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.
P2860
Q33936137-A16AD4FC-045E-4B20-A848-BCECBCD0F76DQ35043812-30C6123D-26CC-4A40-928A-ABFE5F8B8DEBQ35894554-5E0C3FE7-B964-4A02-80AD-2460E906AE57Q36289779-8E311AE3-51FF-4836-A953-7682CE6D3796Q36316219-BFB58599-8535-406F-BA60-C8E26B71B86FQ36333089-165E7CEE-1AEE-46F6-AD92-221CDFED7A1BQ37023852-6701B2C6-DD3D-4C95-83A8-1EB9571877E1Q37289297-63BEAB15-3287-4EEC-A1D9-F917B88AD6A8Q37384190-B8138A68-3741-4EBF-BC6C-365BA6A84EDAQ37639310-0C973C0B-A46E-4417-8426-B43262DA2FBDQ37717838-FBACB911-3306-46C5-A642-D37C3F049595Q38003114-824E48EE-B478-484A-A684-A3BB6E5C84AFQ38350347-111021B9-CA63-4D57-B34C-809858097A6BQ38391087-419EC5CF-57E9-438C-A3A1-8D9D1123ECC5Q38563239-F8AD09FB-870D-4A58-851B-87FABDC14AAAQ38928914-FC572FAF-8E59-42F2-BE88-B468FC37A741Q38957754-E35CC585-BCD7-412B-8667-6A4127514AD5Q39420555-E8B6543C-FB28-4E7C-97F9-E8C85CB7F0D5Q47432485-47AD997F-7C89-470A-8386-DAE0E05D8C31Q47764756-965CFCC7-3850-4AFB-9F04-8A0B7A015CD2Q48921113-59CDD0D7-9EDA-4859-AF07-D9C1C78B008FQ55281492-1C5A5002-65E1-4A9A-AB8A-9061DD998920Q55447873-1F0A2C49-74BB-472E-A9F3-C0997FCCFF7D
P2860
Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Acarbose and metabolic control ...... wly initiated insulin therapy.
@en
Acarbose and metabolic control ...... wly initiated insulin therapy.
@nl
type
label
Acarbose and metabolic control ...... wly initiated insulin therapy.
@en
Acarbose and metabolic control ...... wly initiated insulin therapy.
@nl
prefLabel
Acarbose and metabolic control ...... wly initiated insulin therapy.
@en
Acarbose and metabolic control ...... wly initiated insulin therapy.
@nl
P2093
P2860
P1476
Acarbose and metabolic control ...... wly initiated insulin therapy.
@en
P2093
Acarbose-Insulin Combination Study Group
P2860
P304
P356
10.1111/J.1463-1326.2006.00666.X
P577
2007-11-01T00:00:00Z